Cargando…
Cyclophosphamide-associated enteritis presenting with severe protein-losing enteropathy in granulomatosis with polyangiitis: A case report
BACKGROUND: Although cyclophosphamide (CPA) is the key drug for the treatment of autoimmune diseases including vasculitides, it has some well-known adverse effects, such as myelosuppression, hemorrhagic cystitis, infertility, and infection. However, CPA-associated severe enteritis is a rare adverse...
Autores principales: | Sato, Hiroko, Shirai, Tsuyoshi, Fujii, Hiroshi, Ishii, Tomonori, Harigae, Hideo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160622/ https://www.ncbi.nlm.nih.gov/pubmed/34092982 http://dx.doi.org/10.3748/wjg.v27.i20.2657 |
Ejemplares similares
-
Migratory Aortitis Associated with Granulocyte-colony-stimulating Factor
por: Shirai, Tsuyoshi, et al.
Publicado: (2020) -
The use of tacrolimus for recurrent lupus enteritis: a case report
por: Shirai, Tsuyoshi, et al.
Publicado: (2010) -
Protein‐losing gastroenteropathy with severe hypoalbuminemia associated with Sjögren’s syndrome: A case report and review of the literature
por: Akaishi, Tetsuya, et al.
Publicado: (2019) -
Rituximab vs Cyclophosphamide Induction Therapy for Patients With Granulomatosis With Polyangiitis
por: Puéchal, Xavier, et al.
Publicado: (2022) -
An Innovative Method to Identify Autoantigens Expressed on the Endothelial Cell Surface: Serological Identification System for Autoantigens Using a Retroviral Vector and Flow Cytometry (SARF)
por: Shirai, Tsuyoshi, et al.
Publicado: (2013)